About Prof Beverley Vollenhoven
Head of Gynaecology at Monash Health, Deputy Head of Obstetrics and Gynaecology in the Department of Obstetrics and Gynaecology Monash University and a clinician at Monash IVF.
Special interests
Qualifications
1998 - Certificate in Reproductive Endocrinology and Infertility (CREI) (RANZCOG)
1995 - Fellow of the Royal Australian College of Obstetricians and Gynaecologists (FRANZCOG)
1994 - Doctor of Philosophy (Ph.D), Monash University
1984 - M.B. B.S. (Hons) Monash University
1983 - Diploma International College of Acupuncture, SRI LANKA
1983 - Membership Sri Lankan College of Acupuncture
Awards and Publications
2010 2013 - NHMRC Grant with Professor Peter Rogers. “Fibroblast Function in Uterine Leiomyomas”.
2004-2006 - RANZCOG Members Research Scholarship
2003 - Faculty of Medicine, Nursing & Health Sciences, Southern Clinical School Award for Distinguished Teaching Service
1998 - ANZ Trustees Grant - APPEL Family Bequest
1996-1997 - Monash University Faculty of Medicine Post-Doctoral Research Scholarship
1991-1993 - NH&MRC Medical Post-Graduate Research Scholarship
1989 - Monash University Post-Graduate Research Scholorship
JOURNAL PUBLICATIONS
1. Vollenhoven BJ, Lawrence AS, Healy DL. Uterine fibroids: a clinical review. British Journal of Obstetrics & Gynaecology, 1990 97; 285-298.
2. Vollenhoven BJ, Shekleton P, McDonald J, Healy DL. Clinical predictors for buserelin acetate treatment of uterine fibroids: a prospective study of 40 women. Fertility & Sterility, 1990 54; 1032-1038.
3. Chipato T, Healy DL, Vollenhoven B, Buckler HM. Pelvic pain complicating LHRH analogue treatment of fibroids. Australian & New Zealand Journal of Obstetrics & Gynaecology, 1991 31; 383-384.
4. Healy DL, Vollenhoven BJ. The role of GnRH agonists in the treatment of uterine fibroids. British Journal of Obstetrics & Gynaecology, 1992 99(suppl 7); 23-26.
5. Vollenhoven BJ, Healy DL. Fibroids: diagnosis and management. Modern Medicine, 1993 36; 46-55.
6. Vollenhoven BJ, McCloud P, Shekleton P, McDonald J, Healy DL. An open study of luteinizing hormone releasing hormone agonists in infertile women with uterine fibroids. Gynecological Endocrinology, 1993 7; 57-61.
7. Vollenhoven BJ, Herington AC, Healy DL. Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium. Journal of Clinical Endocrinology & Metabolism, 1993 76; 1106-1110.
8. Vollenhoven BJ, Herington AC, Healy DL. Messenger RNA encoding the insulin-like growth factors and their binding proteins, in women with fibroids, pretreated with luteinizing hormone-releasing hormone agonists*. Human Reproduction, 1994 9; 214-219.
9. Vollenhoven BJ, Pearce P, Herington AC, Healy DL. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women. Clinical Endocrinology, 1994 40; 537-544.
10. Vollenhoven BJ, Herington AC, Healy DL. Epidermal growth factor and transforming growth factor- in uterine fibroids and myometrium. Gynecologic & Obstetric Investigation, 1995 40; 120-124.
11. Farrell E, Palmer D, Vollenhoven B. Managing the menopause: challenging traditional attitudes. Modern Medicine, 1996 39; 75-80.
12. Vollenhoven B, Selub M, Davidson O, Lefkow H, Henault M, Serpa N, Hung TT. Treating infertility. Controlled ovarian hyperstimulation using human menopausal gonadotropin in combination with intrauterine insemination. Journal of Reproductive Medicine, 1996 41; 658-664.
13. Tadokoro N, Vollenhoven B, Clark S, Baker G, Kovacs G, Burger H, Healy DL. Cumulative pregnancy rates in couples with anovulatory infertility compared with unexplained infertility in an ovulation induction programme. Human Reproduction, 1997 12, 1939-1944.
14. Vollenhoven B. Introduction: the epidemiology of uterine leiomyomas. Bailliere’s Clinical Obstetrics and Gynaecology. International Practice and Research, Uterine Fibroids, 1998 12 (2), 169-176. Vollenhoven B (editor).
15. Vollenhoven B. Conclusion. Bailliere’s Clinical Obstetrics and Gynaecology. International Practice and Research, Uterine Fibroids, 1998, 12 (2), 337-340. Vollenhoven B (editor).
16. Vollenhoven BJ, Healy DL. Short- and long-term effects of ovulation induction. Endocrinology and Metabolism Clinics of North America - Gonadal Disorders, 1998, 27 (4), 903-914. Burger HG, McLachlan RI, (editors).
17. Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids (Cochrane Review). In: The Cochrane Library, Issue 4, 1998. Oxford: Update Software.
18. Harris GM, Stendt CL, Vollenhoven BJ, Gan TE, Tipping PG. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives. American Journal of Hematology, 1999 60, 175-180.
19. Fry A, Meagher S, Vollenhoven B. A case of anaphylactic reaction caused by exposure to a latex probe cover in transvaginal ultrasound scanning. Ultrasound in Obstetrics & Gynecology, 1999 13, 373.
20. Evans A, Vollenhoven B, Healy D. Modern antiestrogens and the coming revolution in women’s health care. Australian & New Zealand Journal of Obstetrics & Gynaecology, 1999 39, 334-340.
21. Vollenhoven B, Clark S, Kovacs G, Burger H, Healy D. Prevalence of gestational diabetes mellitus in polycystic ovarian syndrome (PCOS) patients pregnant after ovulation induction with gonadotrophins. Australian and New Zealand Journal of Obstetrics & Gynaecology, 2000 40, 54-58.
22. Katz MG, Vollenhoven B. The reproductive endocrine consequences of annorexia nervosa. British Journal of Obstetrics & Gynaecology, 2000 107, 707-713.
23. Casey R, Rogers PAW, Vollenhoven BJ. An immunohistochemical analysis of fibroid vasculature. Human Reproduction, 2000 15, 1469-1475.
24. Vollenhoven B. Commentary on “Uterine fibroid risk decreased with current or prolonged oral contraceptive use”. Evidence Based Obstetrics & Gynecology, 2000 2, 69.
25. Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids (Cochrane Review). In: The Cochrane Library, Issue 2, 2001. Oxford: Update Software.
26. The International Recombinant Human Chorionic Gonadotrophin Study Group. Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotrophin (rhCG) and urinary hCG. Fertility & Sterility, 2001 75, 1111-1118.
27. Tong S, Jefferes J, Lopes R, Vollenhoven B. Delayed presentation of uterine perforation and haemorrhagic shock 10 days after surgical termination of pregnancy. Australian and New Zealand Journal of Obstetrics & Gynaecology, 2001 41, 335-336.
28. Ang WC, Farrell E, Vollenhoven B. Effect of hormone replacement therapies and selective estrogen receptor modulators in postmenopausal women with uterine leiomyomas: a literature review. Climacteric, 2001 4, 284-292.
29. Weston GC, Schlipalius ML, Ni Bhuinneain M, Vollenhoven BJ. Will Australian men use male hormonal contraception? A survey of a postpartum population. Medical Journal of Australia, 2002 176, 208-210.
30. Tong S, Meagher S, Vollenhoven B. Sonography: dizygotic twin survival in early pregnancy. Nature, 2002 416, 142.
31. Kovacs GT, Clarke S, Burger HG, Healy DL, Vollenhoven B. Surgical or medical treatment of polycystic ovary syndrome: a cost benefit analysis. Gynecological Endocrinology, 2002 16, 53-55.
32. Vollenhoven B. Commentary on “Small intramural fibroids reduced the chance of ongoing ART pregnancy by half” and “Intramural and subserosal fibroids did not reduce ongoing ART pregnancy rates”. Journal Club in Reproductive Medicine, 2002 Apr. www.ferti.net/fertimagazine/journalclub.
33. Lethaby A, Vollenhoven B. Fibroids (Uterine myomatosis, leiomyomas). Clinical Evidence, 2002 June (7), 1666-1678.
34. Yang J, Vollenhoven B. Pain control in outpatient hysteroscopy. (CME Review Article) Obstetrical & Gynecological Survey, 2002 57, 693-702.
35. Lethaby A, Vollenhoven B, Sowter M. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review. British Journal of Obstetrics & Gynaecology, 2002 109, 1097-1108.
36. Weston G, Vollenhoven B. Is IVF becoming a band aid for social infertility. Australian and New Zealand Journal of Obstetrics & Gynaecology, 2002 42, 476-477.
37. Weston GC, Schlipalius ML, Vollenhoven BJ. Migrant fathers and their attitudes to potential male hormonal contraceptives. Contraception, 2002 66, 351-355.
38. Lethaby A, Vollenhoven B. Fibroids (Uterine myomatosis, leiomyomas). Clinical Evidence, 2003 June (9), 2028-2043. This article has been modified for presentation on www.besttreatments.org an internet site for both doctors and patients seeking evidence based information.
39. Vollenhoven B. Commentary on “Amniocentesis did not increase the risk of second-trimester fetal loss in women with leiomyomata”. Evidence Based Obstetrics & Gynecology, 2003 5, 6-7.
40. Healy D, Rombauts L, Vollenhoven B, Kovacs G, Burmeister L. One triplet pregnancy in 510 controlled ovarian hyperstimulation and intrauterine insemination cycles. Fertility & Sterility, 2003 79, 1449-1451.
41. Weston G, Trajstman AC, Gargett CE, Manuelpillai U, Vollenhoven BJ, Rogers PAW. Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium. Molecular Human Reproduction, 2003 9, 541-549.
42. Weston GC, Ponnampalam A, Vollenhoven BJ, Healy DL, Rogers PAW. Genomics in obstetrics and gynaecology. Australian & New Zealand Journal of Obstetrics & Gynaecology 2003 43, 264-272.
43. Tong S, Zachariah R, Chua B, Vollenhoven B. Hysteroscopy under general anaesthesia, a near painless procedure. Australian & New Zealand Journal of Obstetrics & Gynaecol 2003 43, 344-345.
44. Tong S, Vollenhoven B, Meagher S. Determining zygosity in early pregnancy by ultrasound. Ultrasound in Obstetrics & Gynecology 2004 23, 36-37.
45. Healy D, Rombauts L, Vollenhoven B, Kovacs G, Burmeister L. Reply of the Authors to “One triplet pregnancy in 510 controlled ovarian hyperstimulation and intrauterine insemination cycles”. Fertility & Sterility, 2004 81, 221-222.
46. Tong S, Zachariah R, Chua B, Vollenhoven B. Author reply to “Hysteroscopy under general anaesthesia, a near painless procedure”. Australian & New Zealand Journal of Obstetrics & Gynaecol 2004 44, 172.
47. Lethaby A, Vollenhoven B. Fibroids (Uterine myomatosis, leiomyomas). Clinical Evidence 2004 June (11), 2406-2426.
48. Lethaby A, Vollenhoven B. Fibroids (Uterine myomatosis, leiomyomas). Clinical Evidence 2004 Dec (12), 2563-2585.
49. Lethaby A, Vollenhoven B. Fibroids (Uterine myomatosis, leiomyomas) American Family Physician 2005 71, 1753-1756.
50. Weston GC, Cattrall F, Lederman F, Vollenhoven BJ, Rogers PAW. Differences between the pre-menopausal and post-menopausal uterine fibroid vasculature. Maturitas 2005 51, 343-348.
51. Cattrall FR, Vollenhoven BJ, Weston GC. Anatomical evidence for in-utero androgen exposure in women with polycystic ovary syndrome Fertility & Sterility 2005 84, 1689-1692.
52. Lethaby A, Vollenhoven B. Fibroids (Uterine myomatosis, leiomyomas). Clinical Evidence 2005 Dec (14), 2264-2282.
53. Zaitseva M, Vollenhoven BJ, Rogers PAW. In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells. Molecular Human Reproduction 2006 12, 187-207.
54. Teh W-T, Vollenhoven B, Harris PI. Umbilical endometriosis, a pathology that a gynecologist may encounter when inserting the Veres needle. Fertility & Sterility 2006 86, 1764.
55. Vollenhoven B. Invited response to letter to the Editor from Australian Family Physician. Australian Family Physician 2006 11, 839.
56. Lethaby A, Vollenhoven B. Fibroids (Uterine myomatosis, leiomyomas). Clinical Evidence 2007 May (15), 2284-2295.
57. Zaitseva M, Vollenhoven BJ, Rogers PAW. Retinoic acid pathway genes show significantly altered expression in uterine fibroids when compared with normal myometrium. Molecular Human Reproduction 2007 13, 577-585.
58. Lethaby AE, Vollenhoven BJ. An evidence-based approach to hormonal therapies for premenopausal women with fibroids. Best Practice & Research Clinical Obstetrics and Gynaecology 2008 22, 307-331.
59. Zaitseva M, Vollenhoven BJ, Rogers PA. Retinoids regulate genes involved in retinoic acid synthesis and transport in human myometrial and finbroid smooth muscle cells. Human Reproduction 2008 23, 1076-1086.
60. Fleischer R, Weston GC, Vollenhoven BJ, Rogers PA. Pathophysiology of fibroid disease: angiogenesis and regulation of smooth-muscle proliferation. Best Practice & Research Clinical Obstetrics and Gynaecology 2008 22, 603-614.
61. Rowan K, Meagher S, Teoh M, Vollenhoven B, Choong S, Tong S. Corpus luteum across the first trimester: size and laterality as observed by ultrasound. Fertility & Sterility 2008 90, 1844-1847.
62. Vollenhoven B, Osianlis T, Catt J. Is there an ideal stimulation regimen for IVF for poor responders and does it change with age?. Journal of Assisted Reproduction and Genetics 2008 25, 523-529.
63. Woo J, Tong S, Campbell MJ, Wallace L, Meagher S, Montgomery GW, Chao F, Chan W, Vollenhoven B. Two corpora lutea seen at 6-13 weeks’ gestation infers dizygosity among sponataneous same-sexed dichorionic twins. Twin Research and Human Genetics 2009 12, 180-182.
64. Weston G, Osianlis T, Catt J, Vollenhoven B. Bastocyst transfer does not a cause a sex-ratio imbalance. Fertility & Sterility 2009 92, 1302-1305.
65. Wong RC, Bell RJ, Thunuguntla K, McNamee K, Vollenhoven B. Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users. Contraception 2009 80, 452-456.
66. Ameratunge D, Weston G, Osianlis T, Catt J, Vollenhoven B. In vitro fertilisation (IVF) with donor eggs in post-menopausal women: are there differences in pregnancy outcomes in women with premature ovarian failure compared with women with physiological age-related menopause. Journal of Assisted Reproduction and Genetics 2009 26, 511-514.
67. Lethaby A, Vollenhoven B. Fibroids (Uterine myomatosis, leiomyomas). Clinical Evidence (online) 2011 Jan 11.
68. Fleischer R, Vollenhoven BJ, Weston GC. The effects of chemotherapy and radiotherapy on fertility in premenopausal women. Obstetrical and Gynaecological Survey 2011 66, 248-254.
69. Teede HJ, Misso ML, Deeks AA, Moran LJ, Stuckey BG, Wong JL, Norman RJ, Costello MF; The Guideline Development Groups. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Medical Journal of Australia 2011 195, suppl 65-112.
70. Rombauts L, Onwude JL, Chew HW, Vollenhoven BJ. The predictive value of antral follicle count remains unchanged across the menstrual cycle. Fertility & Sterility 2011 96, 1514-1518.